Breaking News, Collaborations & Alliances

Curative Biotech Engages Sterling Pharma for Clinical Supply of Metformin-Based Ophthalmic Treatment

Sterling will support production of topical metformin ophthalmic drugs intended for use in a first-in-human clinical study.

Author Image

By: Patrick Lavery

Content Marketing Editor

Curative Biotechnology is engaging Sterling Pharmaceutical Services to manufacture clinical supply of a metformin-based topical ophthalmic formulation. Sterling, a Dupo, Ill.-based CDMO, specializes in formulation development and manufacturing of sterile products. It will support production of eye drops intended for use in Curative’s planned first in human clinical study. Curative is a development-stage biomedical company focusing on novel therapies for degenerative eye diseases. How Sterl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters